drugset / Trial / NCT00246441
Paroxetine for Comorbid Social Anxiety Disorder and Alcoholism
Phase 4
Completed
42 enrolled
Medical University of South Carolina
National Institute on Alcohol Abuse and Alcoholism (NIAAA) · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of the study is to determine whether an SSRI, paroxetine, improves social anxiety symptoms and alcohol use in individuals who drink to cope with social anxiety disorder.
Timeline
- Start
- 2002-03
- Primary completion
- 2008-02
- Completion
- 2008-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Paroxetine | Small molecule | 60 mg | — |